|
[1]KAMAL S, ABDELHAKAM S, GHORABA D, et al.The frequency, clinical course, and health related quality of life in adults with Gilbert's syndrome:A longitudinal study[J].BMCGastroenterol, 2019, 19 (1) :22.
|
|
[2]GAMMAL RS, COURT MH, HAIDAR CE, et al.Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for UGT1A1 and atazanavir prescribing[J].Clin Pharmacol Ther, 2016, 99 (4) :363-369.
|
|
[3]GOEL A, AGGARWAL R.Unconjugated hyperbilirubinemia:Ablessing in disguise?[J].J Gastroenterol Hepatol, 2013, 28 (11) :1687-1689.
|
|
[4]GENTILE S, TIRIBELLI C, BALDINI G, et al.Sex differences of nicotinate-induced hyperbilirubinemia in Gilbert's syndrome.Implication of bilitranslocase function[J].J Hepatol, 1985, 1 (4) :417-429.
|
|
[5]BOSMA PJ, CHOWDHURY JR, BAKKER C, et al.The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome[J].N Engl J Med, 1995, 333 (18) :1171-1175.
|
|
[6]HORSFALL LJ, NAZARETH I, PEREIRA SP, et al.Gilbert's syndrome and the risk of death:A population-based cohort study[J].J Gastroenterol Hepatol, 2013, 28 (10) :1643-1647.
|
|
[7]STRASSBURG CP.Gilbert-Meulengracht's syndrome and pharmacogenetics:Is jaundice just the tip of the iceberg?[J].Drug Metab Rev, 2010, 42 (1) :168-181.
|
|
[8]SUN L, LI M, ZHANG L, et al.Differences in UGT1A1 gene mutations and pathological liver changes between Chinese patients with Gilbert syndrome and Crigler-Najjar syndrome typeⅡ[J].Medicine (Baltimore) , 2017, 96 (45) :e8620.
|
|
[9]MARUO Y, NAKAHARA S, YANAGI T, et al.Genotype of UGT1A1 and phenotype correlation between Crigler-Najjar syndrome typeⅡand Gilbert syndrome[J].J Gastroenterol Hepatol, 2016, 31 (2) :403-408.
|
|
[10]BOSMA PJ.Inherited disorders of bilirubin metabolism[J].JHepatol, 2003, 38 (1) :107-117.
|
|
[11]THOGULUVA CHANDRASEKAR V, JOHN S.Gilbert syndrome[DB/OL].StatPearls, Treasure Island (FL) , StatPearls Publishing, 2019.
|
|
[12]VUKOVIC M, RADLOVIC N, LEKOVIC Z, et al.UGT1A1 (TA) n promoter genotype:Diagnostic and population pharmacogenetic marker in serbia[J].Balkan J Med Genet, 2018, 21 (1) :59-68.
|
|
[13]TAKANO M, SUGIYAMA T.UGT1A1 polymorphisms in cancer:Impact on irinotecan treatment[J].Pharmgenomics Pers Med, 2017, 10:61-68.
|
|
[14]BURCHELL B, HUME R.Molecular genetic basis of Gilbert's syndrome[J].J Gastroenterol Hepatol, 1999, 14 (10) :960-966.
|
|
[15]SUGATANI J, KOJIMA H, UEDA A, et al.The phenobarbital response enhancer module in the human bilirubin UDP-glucuronosyltransferase UGT1A1 gene and regulation by the nuclear receptor CAR[J].Hepatology, 2001, 33 (5) :1232-1238.
|
|
[16]SAMPIETRO M, IOLASCON A.Molecular pathology of CriglerNajjar type I and II and Gilbert's syndromes[J].Haematologica, 1999, 84 (2) :150-157.
|
|
[17]NAKAGAWA T, MURE T, YUSOFF S, et al.A homozygous mutation in UGT1A1 exon 5 may be responsible for persistent hyperbilirubinemia in a Japanese girl with Gilbert's syndrome[J].Kobe J Med Sci, 2011, 57 (1) :e26-e31.
|
|
[18]CHIDDARWAR AS, D'SILVA SZ, COLAH RB, et al.Genetic variations in bilirubin metabolism genes and their association with unconjugated hyperbilirubinemia in adults[J].Ann Hum Genet, 2017, 81 (1) :11-19.
|
|
[19]SALOMONE F, LI VOLTI G, ROSSO C, et al.Unconjugated bilirubin, a potent endogenous antioxidant, is decreased in patients with non-alcoholic steatohepatitis and advanced fibrosis[J].J Gastroenterol Hepatol, 2013, 28 (7) :1202-1208.
|
|
[20]TIAN J, ZHONG R, LIU C, et al.Association between bilirubin and risk of non-alcoholic fatty liver disease based on a prospective cohort study[J].Sci Rep, 2016, 6:31006.
|
|
[21]HJELKREM M, MORALES A, WILLIAMS CD, et al.Unconjugated hyperbilirubinemia is inversely associated with non-alcoholic steatohepatitis (NASH) [J].Aliment Pharmacol Ther, 2012, 35 (12) :1416-1423.
|
|
[22]CHANG Y, JUNG HS, YUN KE, et al.Metabolically healthy obesity is associated with an increased risk of diabetes independently of nonalcoholic fatty liver disease[J].Obesity (Silver Spring) , 2016, 24 (9) :1996-2003.
|
|
[23]JANG BK.Elevated serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease[J].Clin Mol Hepatol, 2012, 18 (4) :357-359.
|
|
[24]YESILOVA Z, SERDAR M, ERCIN CN, et al.Decreased oxidation susceptibility of plasma low density lipoproteins in patients with Gilbert's syndrome[J].J Gastroenterol Hepatol, 2008, 23 (10) :1556-1560.
|
|
[25]YANG H, WANG Q, ZHENG L, et al.Clinical significance of UGT1A1 genetic analysis in Chinese neonates with severe hyperbilirubinemia[J].Pediatr Neonatol, 2016, 57 (4) :310-317.
|
|
[26]LONGHI MS, VUERICH M, KALBASI A, et al.Bilirubin suppresses Th17 immunity in colitis by upregulating CD39[J].JCI Insight, 2017, 2 (9) :e92791.
|
|
[27]ZHU L, WANG L, CAO F, et al.Modulation of transport and metabolism of bile acids and bilirubin by chlorogenic acid against hepatotoxicity and cholestasis in bile duct ligation rats:Involvement of SIRT1-mediated deacetylation of FXR and PGC-1alpha[J].J Hepatobiliary Pancreat Sci, 2018, 25 (3) :195-205.
|
|
[28]KAWAMOTO R, NINOMIYA D, SENZAKI K, et al.Mildly elevated serum total bilirubin is negatively associated with hemoglobin A1c independently of confounding factors among community-dwelling middle-aged and elderly persons[J].JCirc Biomark, 2017, 6:1849454417726609.
|
|
[29]LIU J, DONG H, ZHANG Y, et al.Corrigendum:Bilirubin increases insulin sensitivity by regulating cholesterol metabolism, adipokines and PPARgamma levels[J].Sci Rep, 2016, 6:19170.
|
|
[30]HAMOUD AR, WEAVER L, STEC DE, et al.Bilirubin in the liver-gut signaling axis[J].Trends Endocrinol Metab, 2018, 29 (3) :140-150.
|
|
[31]FUJIWARA R, HAAG M, SCHAEFFELER E, et al.Systemic regulation of bilirubin homeostasis:Potential benefits of hyperbilirubinemia[J].Hepatology, 2018, 67 (4) :1609-1619.
|
|
[32]IDELMAN G, SMITH DL, ZUCKER SD.Bilirubin inhibits the upregulation of inducible nitric oxide synthase by scavenging reactive oxygen species generated by the tol-like receptor 4-dependent activation of NADPH oxidase[J].Redox Biol, 2015, 5:398-408.
|
|
[33]LI J, QI LL, WU J.Research advances in the diagnosis of nonalcoholic fatty liver disease in children[J].J Clin Hepatol, 2017, 33 (10) :2025-2029. (in Chinese) 李靖, 戚伶俐, 吴捷.儿童非酒精性脂肪性肝病的诊断进展[J].临床肝胆病杂志, 2017, 33 (10) :2025-2029.
|
|
[34]LUO L, AN P, JIA X, et al.Genetically regulated bilirubin and risk of non-alcoholic fatty liver disease:A mendelian randomization study[J].Front Genet, 2018, 9:662.
|
|
[35]HAHN RZ, ANTUNES MV, VERZA SG, et al.Pharmacokinetic and pharmacogenetic markers of irinotecan toxicity[J].Curr Med Chem, 2018.[Epub ahead of print]
|
|
[36]EHMER U, KALTHOFF S, FAKUNDINY B, et al.Gilbert syndrome redefined:A complex genetic haplotype influences the regulation of glucuronidation[J].Hepatology, 2012, 55 (6) :1912-1921.
|
|
[37]STRASSBURG CP.Hyperbilirubinemia syndromes (GilbertMeulengracht, Crigler-Najjar, Dubin-Johnson, and Rotor syndrome) [J].Best Pract Res Clin Gastroenterol, 2010, 24 (5) :555-571.
|
|
[38]BOON AC, HAWKINS CL, COOMBES JS, et al.Bilirubin scavenges chloramines and inhibits myeloperoxidase-induced protein/lipid oxidation in physiologically relevant hyperbilirubinemic serum[J].Free Radic Biol Med, 2015, 86:259-268.
|
|
[39]BULMER AC, BLANCHFIELD JT, TOTH I, et al.Improved resistance to serum oxidation in Gilbert's syndrome:A mechanism for cardiovascular protection[J].Atherosclerosis, 2008, 199 (2) :390-396.
|
|
[40]STEC DE, JOHN K, TRABBIC CJ, et al.Bilirubin binding to PPARalpha inhibits lipid accumulation[J].PLo S One, 2016, 11 (4) :e0153427.
|
|
[41]GUPTA N, SINGH T, CHAUDHARY R, et al.Bilirubin in coronary artery disease:Cytotoxic or protective?[J].World JGastrointest Pharmacol Ther, 2016, 7 (4) :469-476.
|
|
[42]MCGRATH M, LEPINE J, LEE IM, et al.Genetic variations in UGT1A1 and UGT2B7 and endometrial cancer risk[J].Pharmacogenet Genomics, 2009, 19 (3) :239-243.
|
|
[43]GIL J, SASIADEK MM.Gilbert syndrome:The UGT1A1*28promoter polymorphism as a biomarker of multifactorial diseases and drug metabolism[J].Biomark Med, 2012, 6 (2) :223-230.
|
|
[44]TSEZOU A, TZETIS M, GIANNATOU E, et al.Genetic polymorphisms in the UGT1A1 gene and breast cancer risk in Greek women[J].Genet Test, 2007, 11 (3) :303-306.
|
|
[45]GIRARD H, THIBAUDEAU J, COURT MH, et al.UGT1A1 polymorphisms are important determinants of dietary carcinogen detoxification in the liver[J].Hepatology, 2005, 42 (2) :448-457.
|
DownLoad: